253 related articles for article (PubMed ID: 19023128)
1. Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury.
Ngoh GA; Facundo HT; Hamid T; Dillmann W; Zachara NE; Jones SP
Circ Res; 2009 Jan; 104(1):41-9. PubMed ID: 19023128
[TBL] [Abstract][Full Text] [Related]
2. O-linked beta-N-acetylglucosamine: a new piece of the cardioprotection puzzle?
Downey JM; Cohen MV
Circ Res; 2009 Jan; 104(1):7-8. PubMed ID: 19118281
[No Abstract] [Full Text] [Related]
3. O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death.
Ngoh GA; Hamid T; Prabhu SD; Jones SP
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1711-9. PubMed ID: 19734355
[TBL] [Abstract][Full Text] [Related]
4. Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition.
Ngoh GA; Watson LJ; Facundo HT; Dillmann W; Jones SP
J Mol Cell Cardiol; 2008 Aug; 45(2):313-25. PubMed ID: 18539296
[TBL] [Abstract][Full Text] [Related]
5. Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes.
Ngoh GA; Watson LJ; Facundo HT; Jones SP
Amino Acids; 2011 Mar; 40(3):895-911. PubMed ID: 20798965
[TBL] [Abstract][Full Text] [Related]
6. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2.
Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1509-20. PubMed ID: 18367586
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotection by N-acetylglucosamine linkage to cellular proteins.
Jones SP; Zachara NE; Ngoh GA; Hill BG; Teshima Y; Bhatnagar A; Hart GW; Marbán E
Circulation; 2008 Mar; 117(9):1172-82. PubMed ID: 18285568
[TBL] [Abstract][Full Text] [Related]
8. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
9. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety.
Kim EJ; Perreira M; Thomas CJ; Hanover JA
J Am Chem Soc; 2006 Apr; 128(13):4234-5. PubMed ID: 16568991
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
Park SY; Ryu J; Lee W
Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells.
Krześlak A; Jóźwiak P; Lipińska A
Oncol Rep; 2011 Sep; 26(3):743-9. PubMed ID: 21637923
[TBL] [Abstract][Full Text] [Related]
12. The intracellular fate of zonula occludens 2 is regulated by the phosphorylation of SR repeats and the phosphorylation/O-GlcNAcylation of S257.
Quiros M; Alarcón L; Ponce A; Giannakouros T; González-Mariscal L
Mol Biol Cell; 2013 Aug; 24(16):2528-43. PubMed ID: 23804652
[TBL] [Abstract][Full Text] [Related]
13. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
[TBL] [Abstract][Full Text] [Related]
14. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
15. Danhong injection protects cardiomyocytes against hypoxia/reoxygenation- and H2O2-induced injury by inhibiting mitochondrial permeability transition pore opening.
Duan ZZ; Li YH; Li YY; Fan GW; Chang YX; Yu B; Gao XM
J Ethnopharmacol; 2015 Dec; 175():617-25. PubMed ID: 26320687
[TBL] [Abstract][Full Text] [Related]
16. Role of the O-linked β-N-acetylglucosamine in the cardioprotection induced by isoflurane.
Hirose K; Tsutsumi YM; Tsutsumi R; Shono M; Katayama E; Kinoshita M; Tanaka K; Oshita S
Anesthesiology; 2011 Nov; 115(5):955-62. PubMed ID: 21876430
[TBL] [Abstract][Full Text] [Related]
17. Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ.
Balcewich MD; Stubbs KA; He Y; James TW; Davies GJ; Vocadlo DJ; Mark BL
Protein Sci; 2009 Jul; 18(7):1541-51. PubMed ID: 19499593
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc Signaling Augmentation Protects Human Corneal Endothelial Cells from Oxidative Stress via AKT Pathway Activation.
Yoon CK; Yoon SY; Hwang JS; Shin YJ
Curr Eye Res; 2020 May; 45(5):556-562. PubMed ID: 31920129
[No Abstract] [Full Text] [Related]
19. Dissecting PUGNAc-mediated inhibition of the pro-survival action of insulin.
Teo CF; El-Karim EG; Wells L
Glycobiology; 2016 Nov; 26(11):1198-1208. PubMed ID: 27072814
[TBL] [Abstract][Full Text] [Related]
20. O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program.
Francisco H; Kollins K; Varghis N; Vocadlo D; Vosseller K; Gallo G
Dev Neurobiol; 2009 Feb 1-15; 69(2-3):162-73. PubMed ID: 19086029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
